Radboud University Nijmegen

About: Radboud University Nijmegen is a education organization based out in Nijmegen, Gelderland, Netherlands. It is known for research contribution in the topics: Population & Randomized controlled trial. The organization has 35417 authors who have published 83035 publications receiving 3285064 citations. The organization is also known as: Catholic University of Nijmegen & Radboud University.

Identifying best existing practice for characterization modeling in life cycle impact assessment

Abstract: Life cycle impact assessment (LCIA) is a field of active development. The last decade has seen prolific publication of new impact assessment methods covering many different impact categories and providing characterization factors that often deviate from each other for the same substance and impact. The LCA standard ISO 14044 is rather general and unspecific in its requirements and offers little help to the LCA practitioner who needs to make a choice. With the aim to identify the best among existing characterization models and provide recommendations to the LCA practitioner, a study was performed for the Joint Research Centre of the European Commission (JRC). Existing LCIA methods were collected and their individual characterization models identified at both midpoint and endpoint levels and supplemented with other environmental models of potential use for LCIA. No new developments of characterization models or factors were done in the project. From a total of 156 models, 91 were short listed as possible candidates for a recommendation within their impact category. Criteria were developed for analyzing the models within each impact category. The criteria addressed both scientific qualities and stakeholder acceptance. The criteria were reviewed by external experts and stakeholders and applied in a comprehensive analysis of the short-listed characterization models (the total number of criteria varied between 35 and 50 per impact category). For each impact category, the analysis concluded with identification of the best among the existing characterization models. If the identified model was of sufficient quality, it was recommended by the JRC. Analysis and recommendation process involved hearing of both scientific experts and stakeholders. Recommendations were developed for 14 impact categories at midpoint level, and among these recommendations, three were classified as “satisfactory” while ten were “in need of some improvements” and one was so weak that it has “to be applied with caution.” For some of the impact categories, the classification of the recommended model varied with the type of substance. At endpoint level, recommendations were only found relevant for three impact categories. For the rest, the quality of the existing methods was too weak, and the methods that came out best in the analysis were classified as “interim,” i.e., not recommended by the JRC but suitable to provide an initial basis for further development. The level of characterization modeling at midpoint level has improved considerably over the last decade and now also considers important aspects like geographical differentiation and combination of midpoint and endpoint characterization, although the latter is in clear need for further development. With the realization of the potential importance of geographical differentiation comes the need for characterization models that are able to produce characterization factors that are representative for different continents and still support aggregation of impact scores over the whole life cycle. For the impact categories human toxicity and ecotoxicity, we are now able to recommend a model, but the number of chemical substances in common use is so high that there is a need to address the substance data shortage and calculate characterization factors for many new substances. Another unresolved issue is the need for quantitative information about the uncertainties that accompany the characterization factors. This is still only adequately addressed for one or two impact categories at midpoint, and this should be a focus point in future research. The dynamic character of LCIA research means that what is best practice will change quickly in time. The characterization methods presented in this paper represent what was best practice in 2008–2009.

Personal familiarity influences the processing of upright and inverted faces in infants.

Abstract: Infant face processing becomes more selective during the first year of life as a function of varying experience with distinct face categories defined by species, race, and age. Given that any individual face belongs to many such categories (e.g. A young Caucasian man’s face) we asked how the neural selectivity for one aspect of facial appearance was affected by category membership along another dimension of variability. 6-month-old infants were shown upright and inverted pictures of either their own mother or a stranger while event-related potentials (ERPs) were recorded. We found that the amplitude of the P400 (a face-sensitive ERP component) was only sensitive to the orientation of the mother’s face, suggesting that “tuning” of the neural response to faces is realized jointly across multiple dimensions of face appearance. .

A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.

Abstract: Large-scale systematic resequencing has been proposed as the key future strategy for the discovery of rare, disease-causing sequence variants across the spectrum of human complex disease. We have sequenced the coding exons of the X chromosome in 208 families with X-linked mental retardation (XLMR), the largest direct screen for constitutional disease-causing mutations thus far reported. The screen has discovered nine genes implicated in XLMR, including SYP, ZNF711 and CASK reported here, confirming the power of this strategy. The study has, however, also highlighted issues confronting whole-genome sequencing screens, including the observation that loss of function of 1% or more of X-chromosome genes is compatible with apparently normal existence.

Measurement of the Depth of Maximum of Extensive Air Showers above 10(18) eV

Abstract: We describe the measurement of the depth of maximum, Xmax, of the longitudinal development of air showers induced by cosmic rays. Almost four thousand events above 10^18 eV observed by the fluorescence detector of the Pierre Auger Observatory in coincidence with at least one surface detector station are selected for the analysis. The average shower maximum was found to evolve with energy at a rate of (106 +35/-21) g/cm^2/decade below 10^(18.24 +/- 0.05) eV and (24 +/- 3) g/cm^2/decade above this energy. The measured shower-to-shower fluctuations decrease from about 55 to 26 g/cm^2. The interpretation of these results in terms of the cosmic ray mass composition is briefly discussed.

Which drugs cause preventable admissions to hospital? A systematic review

Abstract: Aim: Previous systematic reviews have found that drug-related morbidity accounts for 4.3% of preventable hospital admissions. None, however, has identified the drugs most commonly responsible for preventable hospital admissions. The aims of this study were to estimate the percentage of preventable drug-related hospital admissions, the most common drug causes of preventable hospital admissions and the most common underlying causes of preventable drug-related admissions. Methods: Bibliographic databases and reference lists from eligible articles and study authors were the sources for data. Seventeen prospective observational studies reporting the proportion of preventable drug-related hospital admissions, causative drugs and/or the underlying causes of hospital admissions were selected. Included studies used multiple reviewers and/or explicit criteria to assess causality and preventability of hospital admissions. Two investigators abstracted data from all included studies using a purpose-made data extraction form. Results: From 13 papers the median percentage of preventable drug-related admissions to hospital was 3.7% (range 1.4-15.4). From nine papers the majority (51%) of preventable drug-related admissions involved either antiplatelets (16%), diuretics (16%), nonsteroidal anti-inflammatory drugs (11%) or anticoagulants (8%). From five studies the median proportion of preventable drug-related admissions associated with prescribing problems was 30.6% (range 11.1-41.8), with adherence problems 33.3% (range 20.9-41.7) and with monitoring problems 22.2% (range 0-31.3). Conclusions: Four groups of drugs account for more than 50% of the drug groups associated with preventable drug-related hospital admissions. Concentrating interventions on these drug groups could reduce appreciably the number of preventable drug-related admissions to hospital from primary care.